Distinct Mechanisms of Tumor Resistance to NK Killing: Of Mice and Men

    loading  Checking for direct PDF access through Ovid

Abstract

Tumors cells can release natural killer (NK) cell ligands for activating receptor NKG2D that are thought to inhibit NK cell function. In a recent issue of Science, Deng et al. (2015) show that, unexpectedly, a soluble NKG2D ligand can enhance anti-tumor NK cell activity.

Related Topics

    loading  Loading Related Articles